2021
DOI: 10.1093/neuros/nyab184
|View full text |Cite
|
Sign up to set email alerts
|

Genome-Wide Association Study Identifies Genetic Risk Factors for Spastic Cerebral Palsy

Abstract: BACKGROUND Although many clinical risk factors of spastic cerebral palsy (CP) have been identified, the genetic basis of spastic CP is largely unknown. Here, using whole-genome genetic information linked to a deidentified electronic health record (BioVU) with replication in the UK Biobank and FinnGen, we perform the first genome-wide association study (GWAS) for spastic CP. OBJECTIVE To define the genetic basis of spastic CP.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
11
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 50 publications
0
11
0
Order By: Relevance
“…17,18 GWAS was performed as previously described. 19,20 Whole-genome genotyping was performed using HumanOmniExpressExome BeadChip (Illumina), Human-OmniExpress, HumanExome BeadChip (Illumina), UK BiLEVE Axiom Array (Applied Biosystems), or UK Biobank Axiom Array (Applied Biosystems). The 1000 genome, 21 Haplotype Reference Consortium, and IMPUTE4 (IMPUTE) 16 were used as reference panels to guide imputation of rare and nongenotyped variants.…”
Section: Genome-wide Association Study Analysismentioning
confidence: 99%
“…17,18 GWAS was performed as previously described. 19,20 Whole-genome genotyping was performed using HumanOmniExpressExome BeadChip (Illumina), Human-OmniExpress, HumanExome BeadChip (Illumina), UK BiLEVE Axiom Array (Applied Biosystems), or UK Biobank Axiom Array (Applied Biosystems). The 1000 genome, 21 Haplotype Reference Consortium, and IMPUTE4 (IMPUTE) 16 were used as reference panels to guide imputation of rare and nongenotyped variants.…”
Section: Genome-wide Association Study Analysismentioning
confidence: 99%
“…The copyright holder for this preprint this version posted March 14, 2022. ; https://doi.org/10.1101/2022.03.12.22272299 doi: medRxiv preprint described. 34,43 Splicing quantitative trait loci (sQTL) was used to determine the potential impact of a SNP on alternative splicing. 44 In addition, we used Haploreg, 45 a functional genomics tool to explore the function of variants in non-coding regions of the genome.…”
Section: Functional Genomics Analysismentioning
confidence: 99%
“…10 GWAS was performed as previously described. 34,35 Whole-genome genotyping was performed using Illumina HumanOmniExpressExome BeadChip. 10 Imputation was performed using the 1000 genome reference panel, 36 Haplotype Reference Consortium, or the UK10K using IMPUTE4 software.…”
Section: Genome Wide Association Study Analysismentioning
confidence: 99%
See 1 more Smart Citation
“…Over the past decade, genomewide association studies (GWASs) have emerged as one of the major approaches to identifying underlying genetic variants associated with CP-related diseases or traits, such as epilepsy and autism [24][25][26] . However, until 2021, only one GWAS was performed, among 604 patients with spastic CP, and this study identi ed an association of rs78686911 with European-originated spastic CP 27 . In the gnomAD database, the allele frequencies of rs78687911 in European and East-Asian populations were 0.032 and 0, respectively.…”
mentioning
confidence: 99%